Elinzanetant (NT-814): a novel, non-hormonal dual NK-1,3 receptor antagonist for the treatment of vasomotor symptoms - key findings from the Phase 2 SWITCH-1 study
Titel:
Elinzanetant (NT-814): a novel, non-hormonal dual NK-1,3 receptor antagonist for the treatment of vasomotor symptoms - key findings from the Phase 2 SWITCH-1 study
Auteur:
Panay, Nicholas Anderson, Richard A Joffe, Hadine Caetano, Cecilia Pawsey, Steve Seitz, Christian Zuurman, Lineke Simon, James